Infections in polymyositis and in dermatomyositis;Infections au cours des polymyosites et des dermatomyosites

Presse Medicale

Volumn 38, Issue 2, 2009, Pages 303-316

  Marie, Isabelle ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE;

AGE DISTRIBUTION; CANDIDA; CD4 LYMPHOCYTE COUNT; CORTICOSTEROID THERAPY; DERMATOMYOSITIS; DIAGNOSTIC VALUE; ESOPHAGUS DISEASE; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INFECTION RATE; INTERSTITIAL LUNG DISEASE; LYMPHOCYTOPENIA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS JIROVECI; POLYMYOSITIS; PREDICTION; PYOGENIC BACTERIUM; RISK FACTOR; SHORT SURVEY; SKIN CALCIFICATION; VENTILATED PATIENT;

DERMATOMYOSITIS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFECTION; MYCOBACTERIUM INFECTIONS; MYCOSES; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; POLYMYOSITIS; PREDICTIVE VALUE OF TESTS; VACCINATION; VACCINES;

EID: 58649100898     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2008.09.021     Document Type: Short Survey

References (140)

1. Bohan A., and Peter J.B. Polymyositis and dermatomyositis I. N Engl J Med 292 (1975) 344-347
2. Bohan A., and Peter J.B. Polymyositis and dermatomyositis II. N Engl J Med 292 (1975) 403-407
3. Callen J.P. Dermatomyositis. Lancet 355 (2000) 53-57
4. Chérin P., and Marie I. Les nouveaux critères diagnostiques et d'évaluation des polymyosites et dermatomyosites. Rev Méd Interne 26 (2005) 361-367
5. Danko K., Ponyi A., Constantin T., Borgulya G., and Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83 (2004) 35-42
6. Kovacs S.O., and Kovacs S.C. Dermatomyositis. J Am Acad Dermatol 39 (1998) 899-921
7. Marie I., and Dominique S. Atteinte pulmonaire au cours des polymyosites et des dermatomyosites. La pneumopathie interstitielle. Presse Med 359 (2006) 683-695
8. Marie I., Hachulla E., Chérin P., Dominique S., Hatron P.Y., Hellot M.F., et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthrits Rheum 47 (2002) 614-622
9. Marie I., Hachulla E., Hatron P.Y., Hellot M.F., Levesque H., Devulder B., et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors. J Rheumatol 28 (2001) 2230-2237
10. Marie I., Hatron P.Y., Hachulla E., Wallaert B., Michon-Pasturel U., and Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J Rheumatol 25 (1998) 1336-1343
11. Marie I., Hatron P.Y., Levesque H., Hachulla E., Hellot M.F., Michon-Pasturel U., et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine (Baltimore) 78 (1999) 139-147
12. Marie I., Hachulla E., Levesque H., Reumont G., Ducrotte P., Cailleux N., et al. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis. J Rheumatol 26 (1999) 2706-2709
13. Chevrel G., Borsotti J.P., and Miossec P. Lack of evidence for a direct involvement for muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow-up study. Rheumatology (Oxford) 42 (2003) 349-352
14. Chevrel G., Calvet A., Belin V., and Miossec P. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology (Oxford) 39 (2000) 1037-1039
15. Leff R.L., Burgess S.H., Miller F.W., Lova L.A., Targoff I.N., Dalakas M.C., et al. Distinct seasonal patterns in the onset of adult inflammatory myopathy in patients with anti Jo-1 and anti-Signal recognition particle autoantibodies. Arthritis Rheum 34 (1991) 1391-1397
16. Johnson R.W., Williams F.M., Kazi S., Dimachie M.M., and Reveille J.D. Human immunodeficiency virus-associated polymyositis: a longitudinal study outcome. Arthritis Rheum 49 (2003) 172-178
17. Juarez M., Misischia R., and Alarcon G.S. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma and polymyositis/dermatomyositis. Rheum Dis Clin North Am 29 (2003) 163-184
18. Tam P.E., Schimidt A.M., Yttenberg S.R., and Messner R.P. Duration of virus persistence and ist relationship to inflammation during chronic phase of Coxsakie virus B1-induced murine polymyositis. J Lab Clin Med 123 (1994) 346-356
19. Viguier M., Fouéré S., De la Salmonière P., Rabian C., Lebbe C., Dubertret L., et al. Peripheral blood lymphocyte subset counts in patients with dermatomyositis. Clinical correlations and changes following therapy. Medicine (Baltimore) 82 (2003) 82-86
20. Zampieri S., Ghirardello A., Iaccarino L., Briani C., Sarzi-Puttini P., Atzeni F., et al. Polymyositis-dermatomyositis and infections. Autoimmunity 39 (2006) 191-196
21. Chou S.M. Myxovirus like structures in a case of human chronic polymyositis. Science 158 (1967) 1453-1455
22. Bowles N.E., Dubowitz V., Sewry C.A., and Achard L.C. Dermatomyositis, polymyositis and coxsackie-B-virus infection. Lancet 1 (1987) 1004-1007
23. Fox S.A., Finklestone E., Robbines P.D., Mastaglia F.L., and Swanson N.R. Search for persistent enterovirus infection of muscle in inflammatory myopathies. J Neurol Sci 125 (1994) 70-76
24. Jongen P.J.H., Zoll G.J., Beumont M., Melchers W.J.G., van de Putte L.B.A., and Galama J.M.D. Polymyositis and dermatomyositis: no persistence of enteroviruses or encephalomyocarditis virus RNA in muscle. Ann Rheum Dis 52 (1993) 575-578
25. Pellissier J.F., Civatte M., Fernandez C., Bartoli C., Chetaille B., Schleinitz N., et al. La dermatomyosite et la polymyosite. Rev Neurol (Paris) 158 (2002) 934-947
26. Youself G.E., Isenberg D.A., and Mowbray J.F. Detection of enterovirus specific DANN seqeunces in muscle biopsy specimens from patients with adult onset of myositis. Ann Rheum Dis 49 (1990) 310-315
27. Miller F.W., Love L.A., Biswas T., McClintock P.R., Notkins A.L., and Plotz P.H. Viral and host genetic factors influence encephalomyocarditis virus-induced polymyositis in adult mice. Arthritis Rheum 30 (1987) 549-556
28. Strongwater S.L., Dorovini-Zis K., Ball R.D., and Schnitzer T.J. A murine model of polymyositis induced by coxsakie virus B1 (Tucson strain). Arthritis Rheum 27 (1984) 433-442
29. Morgan O.S., Rodgers-Johnson P., Mora C., and Char G. HTLV-1 and polymyositis in Jamaica. Lancet 2 (1989) 1184-1187
30. Christensen M.L., Pachman L.M., Schneiderman R., Patel D.C., and Frideman J.M. Prevalence of coxsackie-B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29 (1986) 1365-1370
31. Alarcon G.S. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma and polymyositis/dermatomyositis. Infect Dis Clin North Am 20 (2006) 849-875
32. Albani S. Infection and molecular mimicry in autoimmune disease of childhood. Clin Exp Rheumatol 12 Suppl. 10 (1994) S35-41
33. Bolz D.D., and Weis J.J. Molecular mimicry to Borrelia burgdorferi: pathway to autoimmunity?. Autoimmunity 37 (2004) 387-392
34. Leff R.L., Love L.A., Miller F.W., Greenberg S.J., Klein E.A., Dalakas M.C., et al. Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle. Lancet 339 (1992) 1192-1194
35. Manta P., Kalfakis N., and Vassilopoulos D. Evidence for seasonal variation in polymyositis. Neuroepidemiology 8 (1989) 262-265
36. Marie I., Hachulla E., Chérin P., Hellot M.F., Herson S., Levesque H., et al. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 53 (2005) 155-165
37. Mathews M.B., and Bernstein R.M. Myositis autoantibodies inhibits histydil-tRNA synthetase. A model for autoimmunity. Nature 2 (1986) 605-607
38. Phillips B.A., Zilko P.J., Garlepp M.J., and Mastaglia F.L. Seasonal occurrence of relapses in inflammatory myopathies: a preliminary study. J Neurol 249 (2002) 441-444
39. Plots P.H. Autoantibodies are anti-idiotype antibodies to viral antibodies. Lancet 2 (1983) 824-826
40. Saito M., Higuchi I., Saito A., Izumo S., Usuku K., Bangham C.R.M., et al. Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 186 (2002) 1231-1241
41. Vassilopoulos D., Chalasani P., Jurado R.J., Workowski K., and Agudelo C.A. Musculoskeletal infections in patients with human immunodeficiency virus infection. Medicine (Baltimore) 76 (1997) 284-294
42. Walker E.J., and Jeffrey P.D. Polymyositis and molecular mimicry, a mechanism of autoimmunity. Lancet 13 (1986) 605-607
43. Massa M., Costouros N., Mazzoli F., De Benedetti F., La Cava A., Le T., et al. Self epitopes shared between human skeletal myosine and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis. Arthritis Rheum 46 (2002) 3015-3025
44. Pachman L.M., Lipton R., Ramsey-Goldman R., Shamiyeh E., Abbott K., Mendez E.P., et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 53 (2005) 166-172
45. Godeau B., Boudjadja A., Dhainaut J.F., Schlemmer B., Chastang C., Brunet F., et al. Outcome of patients with systemic rheumatic disease admitted to medical intensive care units. Ann Rheum Dis 51 (1992) 627-631
46. Miller F.W., Love L.A., Barbieri S.A., Balow J.E., and Plotz P.H. Lymphocyte activation markers in idiopathic myositis: changes with disease activity and differences among clinical and autoantibody subgroups. Clin Exp Immunol 81 (1990) 373-379
47. Benveniste O., Chérin P., Maisonobe T., Merat R., Chosidow O., Mouthon L., et al. Severe perturbations of the blood T cell repertoire in polymyositis, but not in dermatomyositis patients. J Immunol 167 (2001) 3521-3529
48. Kadoya A., Okada J., Iikuni Y., and Kondo H. Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis/dermatomyositis or systemic lupus erythematosus. J Rheumatol 23 (1996) 1186-1188
49. Schwarz M.I. Thoracic manifestations of the systemic autoimmune diseases. The lung in polymyositis. Clin Chest Med 19 (1998) 701-712
50. Stuck A.E., Minder C.E., and Frey F.J. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 11 (1989) 954-963
51. Agarwal S.K., and Marshall Jr. G.D. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 21 (2001) 147-155
52. Clements P.J., and Davis J. Cytotoxic drugs: their clinical application to the rheumatic diseases. Semin Arthritis Rheum 15 (1986) 231-254
53. Ginsburg C., Guillevin L., Sauvaget F., Lhote F., Jarrousse B., and Komarover H. Maladies systémiques traitées par corticoïdes, échanges plasmatiques et cyclophosphamide : complications infectieuses et lymphopénie. Ann Med Interne 144 (1993) 15-19
54. Rowin J., Amato A.A., Deisher N., Cursio J., and Meriggioli M.N. Mycophenolate mofetil in dermatomyositis: is it safe?. Neurology 66 (2006) 1245-1247
55. Carrie F., Roblot P., Bouquet S., Delon A., Roblot F., and Becq-Giraudon B. Rifampicin-induced nonresponsiveness of giant cell arteritis to prednisone treatment. Arch Intern Med 154 (1994) 1521-1524
56. Chosidow O., and Herson S. Pharmacocinétique des corticoïdes. Ann Med Interne 145 suppl. 2 (1994) 19-21
57. Billaud E.M., Ropers J., Fortineau N., Kreft-Jais C., and Babany G. Analyse critique des interactions médicamenteuses de la ciclosporine. Thérapie 47 (1992) 335-342
58. Tani K., Tomioka R., Sato K., Furukawa C., Nakajima T., Toyota Y., et al. Comparison of clinical course of polymyositis and dermatomyositis: a follow-up in Tokushima University Hospital. J Med Invest 54 (2007) 295-302
59. Bahner D., Meller J., Stiefel M., and Nau R. Juvenile dermatomyositis - akutes rezidiv oder sepsis?. Nervenarzt 70 (1999) 547-551
60. Moore E.C., Cohen F., Douglas S.D., and Gutta V. Staphylococcal infections in childhood dermatomyositis-association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect. Ann Rheum Dis 51 (1992) 378-383
61. Spalding S.J., Meza M.P., Ranganathan S., and Hirsch R. Staphylococcus aureus panniculitis complicating juvenile dermatomyositis. Pediatrics 119 (2007) e528-e530
62. Bléry M., Lacert P., and Touboul A. Lithiasis and bilateral necrosis of the ureters occurring during dermatomyositis. A definite entity or a coincidence?. J Radiol Electrol Med Nucl 59 (1978) 279-282
63. Duarte R.J., Denes F.T., and Sallum A.M. Ureteral calcinosis in juvenile dermatomyositis. Successful precocious surgical management. Int Braz J Urol 32 (2006) 574-577
64. Le Guillou M., Richard F., L'Hénaff F., Ferriere J.M., Durand J., Lacert P., et al. Bilateral ureteral necrosis in a child with dermatomyositis. Eur Urol 6 (1980) 190-191
65. Casademont J., Roger N., Pedrol E., Garcia F., Herrero C., and Grau J.M. Streptococcal myositis as a complication of juvenile dermatomyositis. Neuromuscul Disord 1 (1991) 375-377
66. Gelfand M.S., Holladay R., Bertorini T., and Adams R.F. Staphylococcal pyomyositis with idiopathic dermatomyositis. J Tenn Med Assoc 82 (1989) 243-244
67. Soriano E.R., Barcan L., Clara L., Imamura P., and Catoggio L.J. Streptococcus pyomyositis occurring in a patient with dermatomyositis in a country with temperate climate. J Rheumatol 19 (1992) 1305-1307
68. Hashimoto A., Okuyama R., Watanabe H., Tagami H., and Aiba S. Cytomegalovirus infection complicating immunosuppressive therapy for dermatomyositis. Acta Derm Venereol 86 (2006) 535-537
69. Kim H.A., Yoo C.D., Baek H.J., Lee E.B., Ahn C., Hans J.S., et al. Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population. Clin Exp Rheumatol 16 (1998) 9-13
70. Hernandez-Cruz B., Sifuentes-Osornio J., Ponce-de-Leon Rosales S., Ponce-de-Leon Garduno A., and Diaz-Jouanen E. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases. A case-series. Clin Exp Rheumatol 17 (1999) 289-296
71. Davidson G.S., Voorneveld C.R., and Krishnan N. Tuberculous infection of skeletal muscle in a case of dermatomyositis. Muscle Nerve 17 (1994) 730-732
72. Huang K.L., Chang D.M., and Lu J.J. Tuberculosis of skeletal muscle in a case of polymyositis. Scand J Rheumatol 28 (1999) 380-382
73. Liu C.H., Liu W.C., and Chen L.W. Tuberculous myofasciitis in dermatomyositis. Clin Rheumatol 27 (2008) 7-9
74. Mukhopadhyay C., Garg A., and Ayyagari A. First documented cure of a suggestive exogenous reinfection in polymyositis with same but multidrug resistant M. tuberculosis. BMC Infectious Diseases 4 (2004) 63
75. Ravn P., Munk M.E., Andersen A.B., Lundgren B., Nielsen L.N., Lillebaek T., et al. Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand J Infect Dis 36 (2004) 499-501
76. Yoshida Y., Nakayama J., Furue M., and Matsuda T. Dermatomyositis with tuberculous fasciitis. Eur J Dermatol 14 (2004) 123-124
77. Skogberg K., Ruutu P., Tukiainen P., and Valtonen V. Effect of immunosuppressive therapy on the clinical presentation and outcome of tuberculosis. Clin Infect Dis 17 (1993) 1012-1017
78. Algayres J.P., Mayaudon H., Godeau B., Schill H., Valmary J., Maurel C., et al. Atteinte sous-cutanée extensive à Mycobacterium kansasii au cours d'une dermatomyosite. Ann Med Interne 141 (1990) 633-635
79. Banuls J., Ramon R., Pascual E., Navas J., Betlloch I., and Botella R. Mycobacterium chenolae infection resistant to clarithromycin in a patient with dermatomyositis. Br J Dermatol 143 (2000) 1345
80. Barcat D., Mercie P., Constans J., Traissac T., Le Clouerec G., Texier-Maugein J., et al. Mycobacterium avium complex infection associated with bifocal synovitis in a patient with dermatomyositis. Clin Infect Dis 26 (1998) 1004-1005
81. Barton A., Bernstein R.M., Struthers J.K., and O'Neill T.W. Mycobacterium marinum infection causing septic arthritis and osteomyelitis. Br J Rheumatol 36 (1997) 1207-1209
82. Bedlow A.J., Vittay G.I., Staphenson J., Cooke N.T., and Holden C.A. Deep cutaneous infection with Mycobacterium avium-intracellulare complex in an immunosuppressed patient with dermatomyositis. Br J Dermatol 139 (1998) 920-922
83. Leung Y.Y., Choi K.W., Ho K.M., and Kun E.W.L. Disseminated cutaneous infection with Mycobacterium chelonae mimicking panniculitis in a patient with dermatomyositis. Hong Kong Med J 11 (2005) 515-519
84. Marie I., Heliot P., Roussel F., Hervé F., Muir J.F., and Levesque H. Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology (Oxford) 44 (2005) 1201-1202
85. Nunez J.M., Monteagudo I., Lopez-Longo F.J., Cobeta J.C., and Rivera J. Disseminated Mycobacterium avium-intracellulare infection in a patient with polymyositis. Arthritis Rheum 32 (1989) 934-936
86. Schaller M., Korting H.C., Meurer M., and Schirren C.G. Generalized Mycobacterium-intracellulare infection due to immunosuppressive therapy of paraneoplastic dermatomyositis. Hautarzt 48 (1997) 118-121
87. Shih J.Y., Hsueh P.R., Chang Y.L., Lin S.F., Teng L.J., and Luh K.T. Pyomyositis due tom Mycobacterium haemophilum in a patient with polymyositis and long-term steroid use. Clin Infect Dis 26 (1998) 505-507
88. Yuen K., Fam A.G., and Simor A. Mycobacterium xenopi arthritis. J Rheumatol 25 (1998) 1016-1018
89. Auzary C., Mouthon L., Soilleux M., Cohen P., Boiron P., and Guillevin L. Localized subcutaneous Nocardia farcinica abscess in a woman with overlap syndrome between systemic scleroderma and polymyositis. Ann Med Interne 150 (1999) 582-584
90. Gupta D., Misra R., Agarwal P., Baija S.S., Dhole T.N., and Ayyagiri A. Hospital acquired pulmonary nocardiosis complicating polymyositis. J Assoc Physicians India 43 (1995) 641-642
91. Ikeue T., Ueshima K., Watanabe S., Sugita S., Horikawa S., Suzuki Y., et al. Pneumonia caused by Nocardia nova. Nihon Kokyuki Gakkai Zasshi 39 (2001) 492-497
92. Klein-Gitelman M.S., and Szer I.S. Disseminated Nocardia brasiliensis infection: an unusual complication of immunosuppressive treatment for childhood dermatomyositis. J Rheumatol 18 (1991) 1243-1246
93. Kofteridis D., Mantadakis E., Mixaki I., Stefanidou M., Maraki S., Alexandrakis M., et al. Primary cutaneous nocardiosis in 2 patients on immunosuppressants. Scand J Infect Dis 37 (2005) 507-510
94. La Civita L., Battiloro R., and Celano M. Nocardia pleural empyema complicating anti-Jo1 positive polymyositis during immunoglobulin and steroid therapy. J Rheumatol 28 (2001) 215-217
95. Shah N.M., Balakrishnan C., Mangat G.K., and Joshi V.R. Pulmonary nocardial infection and Pseudomonas infection of the tongue in a patient with dermatomyositis. J Assoc Physicians India 49 (2001) 850-851
96. Savage M.W., Clarke C.E., and Yuill G.M. Silent nocardia cerebral abscesses in treated dermatomyositis. Postgrad Med J 66 (1990) 582-583
97. Marie I., Hervé F., Kerleau J.M., François A., and Levesque H. Helicobacter heilmanii in polymyositis. Eur J Intern Med 13 (2006) 213-214
98. Sepkowitz K.A. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34 (2002) 1098-1107
99. Godeau B., Coutant-Perronne V., Le Thi Huong D., Guillevin L., Magadur G., De Bandt M., et al. Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21 (1994) 246-251
100. Li J., Huang X.M., Fang W.G., and Zeng X.J. Pneumocystis carinii pneumonia in patients with connective tissue disease. J Clin Rheumatol 12 (2006) 114-117
101. Taillan B., Ferrari E., Vinti H., Fuzibet J.G., and Dujardin P. Pneumocystosis in dermatopolymyositis treated with low-dose methotrexate. Rev Rhum Mal Osteoartic 58 (1991) 76-77
102. Ward M.M., and Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases. Arthritis Rheum 42 (1999) 780-789
103. Yale S.H., and Limper A.H. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71 (1996) 5-13
104. Falagas M.E., Manta K.G., Betsi G.I., and Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26 (2007) 663-670
105. Mounib B., Cabane J., Blum L., Picard O., Wattiaux M.J., and Imbert J.C. Le risque de pneumocystose nosocomiale chez les immunodéprimés non infectés par le virus de l'immunodéficience humaine. Rev Med Interne 15 (1994) 95-100
106. Arend S.M., Kroon F.P., and van't Wout J.W. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993: an analysis of 78 cases. Ann Intern Med 155 (1995) 2436-2441
107. Sepkowitz K.A., Brown A.E., and Armstrong D. Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: more patients, same risk. Arch Intern Med 155 (1995) 1125-1128
108. Kovacs J.A., Hiemenz J.W., Macher A.M., Stover D., Murray H.W., Shelhamer J., et al. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100 (1984) 663-671
109. Nenoff P., Horn L.C., Mierzwa M., Leonhardt R., Weidenbach H., Lehmann I., et al. Peracute disseminated fatal Aspergillus fumigatus sepsis as a complication of corticoid-treated systemic lupus erythematosus. Mycoses 38 (1995) 467-471
110. Kaiser L., Huguenin T., Lew P.D., Chapuis B., and Pittet D. Invasive aspergillosis: clinical features of 35 proven cases at a single institution. Medicine (Baltimore) 77 (1998) 188-194
111. Lonneux M., Nolard N., Philippart I., Henkinbrant A., Hamels J., Fastrez J., et al. A case of lymphocytic pneumonitis, myositis, and arthritis associated with exposure to Aspergillus niger. J Allergy Clin Immunol 95 (1995) 1047-1049
112. Henseler T. Mucocutaneous candidiasis in patients with skin diseases. Mycoses 1 (1995) 7-13
113. Lynch III J.P., Schaberg D.R., Kissner D.G., and Kauffman C.A. Cryptococcus laurentii lung abscess. Am Rev Respir Dis 123 (1981) 135-138
114. Morgans M.E., Thomas M.E.M., and MacKenzie D.W.R. Successful treatment of systemic cryptococcosis with miconazole. Br Med J 2 (1979) 100-101
115. Miyamoto T., Sasaoka R., Kawaguchi M., Ishioka S., Inoue T., Yamada N., et al. Scedosporium apiospermum skin infection: a case report and review of the literature. J Am Acad Dermatol 39 (1998) 498-500
116. Takei H., Goodman J.C., and Powell S.Z. Cerebral phaeohyphomycosis caused by Cladophialophora bantiana and Fonsecaea monophora: report of three cases. Clin Neuropathol 26 (2007) 21-27
117. Voloshin D.K., Lacomis D., and McMahon D. Disseminated histoplasmosis presenting as myositis and fasciitis in a patient with dermatomyositis. Muscle Nerve 18 (1995) 531-535
118. Nagaoka S., Tani K., Ishigatsubo Y., Chiba J., Kato K., Matsunaga K., et al. Herpes zoster in patients with polymyositis and dermatomyositis. Kansenshogaku Zasshi 64 (1990) 1394-1399
119. Kasifoglu T., Korkmaz C., and Özkan R. Cytomegalovirus-induced interstitial pneumonitis in a patient with dermatomyositis. Clin Rheumatol 25 (2006) 731-733
120. Kim H.R., Kim S.D., Kim S.H., Yoon C.H., Lee S.H., Park S.H., et al. Cytomegalovirus retinitis in a patient with dermatomyositis. Clin Rheumatol 26 (2007) 801-803
121. Maeda M., Maeda A., Wakiguchi H., Murakami N., Sata T., Okada T., et al. Polymyositis associated with primary cytomegalovirus infection. Scand J Infect Dis 32 (2000) 212-214
122. Murota H., Muroi E., Yamaoka T., Hamasaki Y., and Katayama I. Successful treatment with regimen of intravenous gammaglobulin and cyclophosphamide for dermatomyositis accompanied by interstitial pneumonia, opportunistic infection and steroid psychosis. Allergology Int 55 (2006) 199-202
123. Nishi K., Myoh S., Bandoh T., Ohka T., Kurumaya H., Yasui M., et al. An autopsy case of dermatomyositis associated with interstitial pneumonia probably due to cytomegalovirus infection. Nihon Kyobu Shikkan Gakkai Zasshi 30 (1992) 1975-1980
124. Alric L., Partensky J., Reynaud D., Rauzy O., and Duffaut D. Association entre polymyosite et infection par le virus de l'hépatite C. Les difficultés du traitement. Rev Med Interne 21 (2000) 542-546
125. Bauza A., Espana A., and Lloret P. Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection. Eur J Dermatol 13 (2003) 302-304
126. Horsmans Y., and Geubel A.P. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 345 (1995) 1236
127. Marie I., Levesque H., Curtois H., François A., and Riachi G. Polymyositis, cranial neuropathy, autoimmune hepatitis, and hepatitis C. Ann Rheum Dis 59 (2000) 839-840
128. McMurray R.W., and Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 26 (1997) 689-701
129. Nakamura K., Matsumori A., Kusano K.F., Banba K., Taniyama M., Nakamura Y., et al. Hepatitis C virus infection in a patient with dermatomyositis and left ventricular dysfunction. Jpn Circ J 64 (2000) 617-618
130. Nishikai M., Miyairi M., and Kosaka S. Dermatomyositis following infection with hepatitis C virus. J Rheumatol 21 (1994) 1584-1585
131. Ueno Y., Kondo K., Kidokoro N., Kobashi R., Kanaji K., and Matsumara T. Hepatitis C infection and polymyositis. Lancet 346 (1995) 319-320
132. Weidensaul D., Imam T., Holyst M.M., King P.D., and McMurray R.W. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 38 (1995) 437-439
133. Yang C.H., Wu T.S., and Chiu C.T. Chronic hepatitis B reactivation: a word of caution regarding the use of systemic glucocorticosteroid therapy. Br J Dermatol 157 (2007) 587-590
134. Martin III R.W., Hood A.F., and Farmer E.R. Kaposi's sarcoma. Medicine (Baltimore) 72 (1993) 245-261
135. Penn I. The changing pattern of post transplant malignancies. Transplant Proc 23 (1991) 1101-1103
136. Louthrenoo W., Kasitanon N., Mahanuphab P., Bhoopat L., and Thongprasert S. Kaposi's sarcoma in rheumatic diseases. Semin Arthritis Rheum 32 (2003) 326-333
137. Hudnall S.D., Rady P.L., Tyring S.K., and Fish J.C. Hydrocortisone activation of human herpes virus-8 viral DNA replication and gene expression in vitro. Transplantation 67 (1999) 648-652
138. Marie I., Fevre C., Favennec L., Courville P., Bernet J., and Levesque H. Leishmaniose cutanée au cours d'une polymyosite. Rev Méd Interne 27 (2006) 566-568
139. Jarrousse B. Pneumocystose pulmonaire : un risque infectieux opportuniste associé aux maladies systémiques et à leur traitement. Presse Med 25 (1996) 331-332
140. Lortholary O., Généreau T., Jarrousse B., and Guillevin L. Maladies systémiques et infections : questions actuelles. Presse Med 25 (1996) 370-378